Personalized screening for cancers: should we consider polygenic profiling?

被引：8
|
作者：
Pashayan, Nora [1 ]
Guo, Qi [2 ]
Pharoah, Paul D. P. [2 ,3 ]
机构：
[1] UCL, Dept Appl Hlth Res, London WC1E 7HB, England
[2] Univ Cambridge, Dept Oncol, Cambridge, England
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
来源：
PERSONALIZED MEDICINE | 2013年 / 10卷 / 06期
关键词：
cancer; personalized screening; polygenic profiling; BREAST-CANCER; SUSCEPTIBILITY LOCI; PROSTATE; RISK; PREVENTION; PREDICTION;
D O I：
10.2217/pme.13.46
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：511 / 513
页数：3
相关论文
共 50 条
  • [31] Why We Should Focus on Melanoma-Targeted Screening Strategies
    Rat, Cedric
    Dreno, Brigitte
    Nguyen, Jean-Michel
    DERMATOLOGY, 2017, 233 (06) : 480 - 481
  • [32] Lung cancer screening: Should we be excluding people with previous malignancy?
    Cherie P Erkmen
    Larry R Kaiser
    Ashley L Ehret
    World Journal of Respirology, 2016, 6 (01) : 1 - 13
  • [33] When Should We Let Colorectal Cancer Screening Get Personal?
    Lam, Angela Y.
    Lee, Jeffrey K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (02) : 278 - 279
  • [34] Human cancers and mammalian retroviruses: should we worry about bovine leukemia virus?
    Munro, Andrew C.
    Houldcroft, Charlotte
    FUTURE VIROLOGY, 2016, 11 (03) : 163 - 166
  • [35] Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?
    Jeff M. P. Holly
    Li Zeng
    Claire M. Perks
    Cancer and Metastasis Reviews, 2013, 32 : 673 - 705
  • [36] Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?
    Holly, Jeff M. P.
    Zeng, Li
    Perks, Claire M.
    CANCER AND METASTASIS REVIEWS, 2013, 32 (3-4) : 673 - 705
  • [37] Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities
    Walker, Meghan J.
    Blackmore, Kristina M.
    Chang, Amy
    Lambert-Cote, Laurence
    Turgeon, Annie
    Antoniou, Antonis C.
    Bell, Kathleen A.
    Broeders, Mireille J. M.
    Brooks, Jennifer D.
    Carver, Tim
    Chiquette, Jocelyne
    Despres, Philippe
    Easton, Douglas F.
    Eisen, Andrea
    Eloy, Laurence
    Evans, D. Gareth
    Fienberg, Samantha
    Joly, Yann
    Kim, Raymond H.
    Kim, Shana J.
    Knoppers, Bartha M.
    Lofters, Aisha K.
    Nabi, Hermann
    Paquette, Jean-Sebastien
    Pashayan, Nora
    Sheppard, Amanda J.
    Stockley, Tracy L.
    Dorval, Michel
    Simard, Jacques
    Chiarelli, Anna M.
    CANCERS, 2024, 16 (11)
  • [38] Defining Pathologic Upstaging in cT1b Esophageal Cancer: Should We Consider Neoadjuvant Therapy?
    Mann, David R.
    Engelhardt, Kathryn E.
    Gibney, Barry C.
    Batten, Macelyn E.
    Klipsch, Eric C.
    Mukherjee, Rupak
    Bostock, Ian C.
    JOURNAL OF SURGICAL RESEARCH, 2024, 295 : 61 - 69
  • [39] An analysis of screen-detected invasive cancers by grade in the English breast cancer screening programme: are we failing to detect sufficient small grade 3 cancers?
    Blanks, R. G.
    Wallis, M. G.
    Alison, R. J.
    Given-Wilson, R. M.
    EUROPEAN RADIOLOGY, 2021, 31 (04) : 2548 - 2558
  • [40] Coffee consumption and all-cause and cardiovascular mortality in older adults: should we consider cognitive function?
    Lin, Fabin
    Shi, Yisen
    Zou, Xinyang
    Wang, Huaicheng
    Fu, Shibo
    Wang, Xuefei
    Yang, Zeqiang
    Cai, Guofa
    Cai, Guoen
    Wu, Xilin
    FRONTIERS IN NUTRITION, 2023, 10
12345